A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma; ODM derived from:


Versions (1) ▾
  1. 3/18/18
Copyright Holder:
Uploaded on:

March 18, 2018

No DOI assigned. To request one please log in.
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Esophageal Carcinoma NCT00642239

Eligibility Esophageal Carcinoma NCT00642239

Inclusion Criteria
written informed consent
photographically and histologically proven thoracic esophageal squamous carcinoma
stages 2a-3, and stage 4 with only supraclavicular lymph nodes metastasis defined by ajcc(2002)
radiochemotherapy indication
measurable tumor
adequate hematologic, hepatic and renal function
karnofsky performance status ≥70
age more than 18years and less than 70 years
Exclusion Criteria
pregnancy and lactation
significant neurologic disease
severe liver and renal malfunction,and significant medical illness
previous chemotherapy, radiotherapy or immunotherapy
esophagus hemorrhage and esophagus perforation features